纽维克蒂斯制药 NVCT
$20.91 +$3.15 (+17.74%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $21.00 +0.43%
开盘$18.01
昨收$17.76
当日区间$17.80 – $21.05
成交量258.7K
市值$719.07M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$7.20M-9.1% YoY
净利润-$7.02M-10.8% YoY
摊薄每股收益-$0.30+0.0% YoY
自由现金流-$4.53M-34.6% YoY
经营现金流-$4.53M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-233.3%
资产收益率-122.6%
投入资本回报率-241.2%
流动比率1.68
负债/资产比率59.4%
现金及投资$22.16M
净现金（净负债）$22.16M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $7.20M | $6.26M | $27.57M | $7.62M | $7.79M |
| 销售及管理费用 | $2.51M | $2.15M | $9.42M | $2.53M | $2.02M |
| -管理费用 | $2.51M | $2.15M | $9.42M | $2.53M | $2.02M |
| 研发费用 | $4.68M | $4.11M | $18.15M | $5.09M | $5.77M |
| 营业利润 | -$7.20M | -$6.26M | -$27.57M | -$7.62M | -$7.79M |
| 非经营性利息净收入（支出） | $177,000.00 | $210,000.00 | $1.13M | $303,000.00 | $332,000.00 |
| 非经营性利息收入 | $177,000.00 | $210,000.00 | $1.13M | $303,000.00 | $332,000.00 |
| 税前利润 | -$7.02M | -$6.05M | -$26.44M | -$7.31M | -$7.46M |
| 净利润 | -$7.02M | -$6.05M | -$26.44M | -$7.31M | -$7.46M |
| 持续经营利润 | -$7.02M | -$6.05M | -$26.44M | -$7.31M | -$7.46M |
| 归属母公司净利润 | -$7.02M | -$6.05M | -$26.44M | -$7.31M | -$7.46M |
| 归属普通股股东净利润 | -$7.02M | -$6.05M | -$28.87M | -$7.31M | -$9.89M |
| 基本每股收益 | -$0.30 | -$0.26 | -$1.32 | -$0.31 | -$0.44 |
| 摊薄每股收益 | -$0.30 | -$0.26 | -$1.32 | -$0.31 | -$0.44 |
| 其他优先股股息 | – | – | $2.43M | $0.00 | $2.43M |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $22.38M | $25.40M | $31.71M | $31.71M | $35.59M |
| 流动资产合计 | $22.38M | $25.40M | $31.71M | $31.71M | $35.59M |
| 现金及现金等价物与短期投资 | $22.16M | $25.13M | $31.63M | $31.63M | $35.44M |
| -现金及现金等价物 | $22.16M | $25.13M | $31.63M | $31.63M | $35.44M |
| 其他流动资产 | $216,000.00 | $268,000.00 | $75,000.00 | $75,000.00 | $145,000.00 |
| 非流动资产合计 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 负债合计 | $13.29M | $11.18M | $13.30M | $13.30M | $11.58M |
| 流动负债合计 | $13.29M | $11.18M | $13.30M | $13.30M | $11.58M |
| 应付款 | $5.18M | $4.70M | $6.27M | $6.27M | $6.51M |
| -应付账款 | $5.18M | $4.70M | $6.27M | $6.27M | $6.44M |
| 一年内应计费用 | $92,000.00 | $36,000.00 | $115,000.00 | $115,000.00 | $65,000.00 |
| 一年内递延负债 | $1.39M | – | – | – | – |
| 非流动负债合计 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 股东权益合计 | $9.08M | $14.22M | $18.41M | $18.41M | $24.01M |
| 股东权益 | $9.08M | $14.22M | $18.41M | $18.41M | $24.01M |
| 股本 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -普通股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $121.84M | $119.96M | $118.10M | $118.10M | $116.38M |
| 留存收益 | -$112.76M | -$105.74M | -$99.69M | -$99.69M | -$92.37M |
| -其他应付款 | – | – | – | – | $75,000.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$4.53M | -$6.51M | -$16.01M | -$3.97M | -$4.49M |
| 持续经营经营活动现金流净额 | -$4.53M | -$6.51M | -$16.01M | -$3.97M | -$4.49M |
| 持续经营净利润 | -$7.02M | -$6.05M | -$26.44M | -$7.31M | -$7.46M |
| 营运资金变动 | $780,000.00 | -$2.31M | $4.40M | $1.86M | $1.51M |
| -应付账款及应计费用变动 | $1.01M | -$2.12M | $3.05M | -$115,000.00 | $1.53M |
| -其他流动资产变动 | $52,000.00 | -$193,000.00 | -$1,000.00 | $70,000.00 | $69,000.00 |
| 投资活动现金流净额 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 筹资活动现金流 | $1.56M | $7,000.00 | $29.11M | $166,000.00 | $13.14M |
| 持续经营筹资活动现金流净额 | $1.56M | $7,000.00 | $29.11M | $166,000.00 | $13.14M |
| 普通股发行净额 | $1.57M | $7,000.00 | $31.21M | $248,000.00 | $13.55M |
| 期末现金余额 | $22.16M | $25.13M | $31.63M | $31.63M | $35.44M |
| 现金净变动 | -$2.97M | -$6.50M | $13.10M | -$3.81M | $8.65M |
| 期初现金余额 | $25.13M | $31.63M | $18.53M | $35.44M | $26.79M |
| 自由现金流 | -$4.53M | -$6.51M | -$16.01M | -$3.97M | -$4.49M |
| -其他营运资金变动 | – | – | $1.35M | $1.91M | -$83,000.00 |
| 其他筹资费用净额 | – | – | -$2.10M | -$82,000.00 | -$407,000.00 |
暂无评论——快来第一个聊聊 NVCT。
登录后参与讨论。